Medical Treatments for Prostate CancerThere are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer. Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy - an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) - surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery - this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence. Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy. The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy's side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped. |
| dcvax prostate |
|
Northwest Biotherapeutics moves brain cancer treatment past phase Last month the company said that a small phase 1/2 clinical trial of its DCVax-Prostate treatment for late-stage prostate cancer showed promising results in Hematology/Oncology Clinics of North America : Immunotherapy for The DCVax-Prostate vaccine consists of autologous DCs pulsed ex vivo with specific PSMA peptides (PSM-P1 and PSM-P2) that bind to HLA-A2 and are immunogenic Prostate cancer vaccine--Northwest Biotherapeutics: CaPVax, DC1 Prostate cancer vaccine--Northwest Biotherapeutics: CaPVax, DC1/HRPC, DCVax--Prostate. Paper-10692474. Important links ! iHOP - Information Hyperlinked over IngentaConnect Prostate Cancer Vaccine Northwest Biotherapeutics Northwest Biotherapeutics is developing a prostate cancer vaccine based on its proprietary dendritic-cell based vaccine technology (DCVax). SEC Info - Northwest Biotherapeutics Inc - 8-K - For 12/9/02 - EX-10.1 1.6 "DCVAX-PROSTATE PRODUCT" shall mean that version of Northwest's proprietary product that was in Phase III clinical trials in August of 2002 under IND Northwest Biotherapeutics, Inc. - DCVax<sup>^</sup>-Prostate DCVax^-Prostate is an experimental autologous cellular therapy designed to create a specific immune response against a patients cancer. Northwest Biotherapeutics, Inc. - DCVax<sup>^</sup> - Prostate Development stage: DCVax^-Prostate is entering a Phase III clinical trial that was cleared to proceed by the Food and Drug Administration in January of 2005 BioDrugs - Fulltext: Volume 16(3) 2002 p 226-227 Prostate Cancer In a phase I/II trial 16 of 29 patients with late-stage prostate cancer showed disease stabilisation following treatment with DCVax"-prostate. BioDrugs - Abstract: Volume 16(3) 2002 p 226-227 Prostate Cancer 1 The vaccine (DCVaxTM-Prostate, CaPVax, DC1/HRPC) consists of prostate-specific membrane antigen (PSMA)-pulsed autologous dendritic cells and is in phase BioSeeker Group AB - DCVax-prostate - Northwest Biotherapeutics Our drug profiles are updated both through companies own participation and BioSeeker Groups research. Daily updates and work with pharmaceutical research dcvax-prostate+biotherapeutics+patent | most popular | mister-wong.com Are you interested in dcvax-prostate, biotherapeutics or patent, lonza or northwest, biotechnology, cancer or nwbt? If so, Mister Wong is just right for dcvax-prostate | most popular | mister-wong.com Are you interested in biotechnology, nwbt, dcvax-brain, dcvax-prostate, cancer, cancervaccine, pharmaceuticals, pharmaceuticalcompany, vaccine, NORTHWEST BIOTHERAPEUTICS INC - NWBT Securities Registration We are currently developing four DCVax product candidates. Our lead DCVax product candidate, DCVax-Prostate, is a prostate cancer treatment for which we are New options put squeeze on prostate cancer - Drug Topics DCVax-Prostate, from Northwest Biotherapeutics, is in phase III of development. It is an autologous cellular therapy that utilizes a patient's own dendritic Prostate cancer vaccine--Northwest Biotherapeutics: CaPVax, DC1 Prostate cancer vaccine--Northwest Biotherapeutics: CaPVax, DC1/HRPC, DCVax--Prostate. No authors listed MeSH Terms:. Cancer Vaccines/adverse effects Northwest Biotherapeutics, Inc. to Present Favorable Data on OB) today announced it will present favorable long-term follow-up data from advanced-stage prostate cancer patients treated with DCVax-Prostate in a Northwest Biotherapeutics, Inc. to Present New Prostate Cancer The Company's lead DCVax product candidate, DCVax-Prostate, is a prostate cancer treatment that is currently in a pivotal Phase III clinical trial. Northwest Biotherapeutics, Inc. Announces Fourth-Quarter and Full "We expect that our expenses will continue to increase in 2002 as a direct result of our Phase III clinical trial for DCVax-Prostate; Phase II clinical Northwest's DCVax Prostate OK for Ph III.(Pharmaceutical industry Northwest's DCVax Prostate OK for Ph III.(Pharmaceutical industry)(Brief Article). Article, News, Research, Information, Industry & Business News |
| dcvax prostate |
|
cause prostate die from prostate cancer alberta canada massage prostate cancer condition more prostate treatment |